Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome
The Journal of Pediatrics Sep 19, 2017
Minoia F, et al. - The researchers intended to establish and validate a diagnostic score which would aid in distinguishing primary hemophagocytic lymphohistiocytosis (pHLH) from macrophage activation syndrome (MAS) related to systemic juvenile idiopathic arthritis. They suggested that the MH score was a powerful tool that might help in identifying patients who were more likely to have pHLH. Hence, this approach could be prioritized for functional and genetic testing.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries